CABOZANIX (CABOZANTINIB) 60MG TABLETS 30`S

Description

Targeted Treatment for Advanced Cancer

CABOZANIX (Cabozantinib) 60mg Tablets 30’s provide targeted therapy for adults with advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and certain types of thyroid cancer. Cabozantinib inhibits multiple tyrosine kinases, which play a role in tumour growth and spread.

How CABOZANIX Works

Cabozantinib blocks specific enzymes that promote cancer cell growth and blood vessel formation. By disrupting these pathways, CABOZANIX (Cabozantinib) 60mg Tablets 30’s help slow tumour progression and reduce cancer cell proliferation. Additionally, this mechanism supports improved disease control.

Dosage and Administration

Patients typically take one 60mg tablet once daily, on an empty stomach, at least one hour before or two hours after a meal. Taking the medication consistently at the same time each day enhances its effectiveness. Your healthcare provider will tailor the dose based on your condition and response.

Monitoring and Side Effects

Regular monitoring of blood pressure, liver function, and overall health is essential during treatment. Common side effects include fatigue, diarrhoea, nausea, and hand-foot syndrome. However, more serious side effects may require prompt medical attention. Therefore, it’s important to communicate any new symptoms to your healthcare team immediately.

Quality Assurance and Safety

Manufactured under rigorous pharmaceutical standards, CABOZANIX (Cabozantinib) 60mg Tablets 30’s ensure reliable potency and purity. This prescription-only medication should always be used under specialist supervision to guarantee safety and optimal outcomes.

Empowering Cancer Care

By choosing CABOZANIX, patients gain access to a trusted, clinically proven option for managing advanced cancers. With ongoing medical support, this treatment can help improve quality of life and disease management.